Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Drug Design, Development and Therapy
Yehenew A EbstieDawit A Ejigu

Abstract

Despite declining global malaria incidence, the disease continues to be a threat to people living in endemic regions. In 2015, an estimated 214 million new malaria cases and 438,000 deaths due to malaria were recorded. Plasmodium vivax is the second most common cause of malaria next to Plasmodium falciparum. Vivax malaria is prevalent especially in Southeast Asia and the Horn of Africa, with enormous challenges in controlling the disease. Some of the challenges faced by vivax malaria-endemic countries include limited access to effective drugs treating liver stages of the parasite (schizonts and hypnozoites), emergence/spread of drug resistance, and misperception of vivax malaria as nonlethal. Primaquine, the only 8-aminoquinoline derivative approved by the US Food and Drug Administration, is intended to clear intrahepatic hypnozoites of P. vivax (radical cure). However, poor adherence to a prolonged treatment course, drug-induced hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency, and the emergence of resistance make it imperative to look for alternative drugs. Therefore, this review focuses on data accrued to date on tafenoquine and gives insight on the potential role of the drug in preventing relapse and ...Continue Reading

Citations

Nov 28, 2016·Trends in Parasitology·Anna RivkinNeta Regev-Rudzki
Apr 5, 2018·Malaria Journal·Henriette Bosson-VangaDominique Mazier
Apr 5, 2020·Marine Drugs·María Álvarez-BardónRafael Balaña-Fouce
Sep 20, 2018·Drugs·James E Frampton
Mar 25, 2019·Malaria Journal·Edwin G TseMatthew H Todd
May 18, 2019·The Journal of Infectious Diseases·Dana G Mordue, Gary P Wormser
Mar 11, 2017·Malaria Journal·Anna Caroline C AguiarAntoniana U Krettli
Dec 1, 2018·Malaria Journal·Patricia SchlagenhaufPhilippe Gautret
Feb 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anas NajjarRafik Karaman
Jun 22, 2017·Current Infectious Disease Reports·Johanna P Daily
Feb 20, 2020·Biochemistry·Kuan-Yi Lu, Emily R Derbyshire
Mar 27, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Min ZhouThomas Efferth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved